Ertapénem intraveineux ou sous-cutané pour le traitement des infections urinaires à entérobactérie sécrétrice de BLSE

Prakash, 2009, Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases, Antimicrob Agents Chemother, 53, 1278, 10.1128/AAC.01519-08 Tomera, 2002, Ertapenem versus ceftriaxone followed by appropriate oral therapy for treatment of complicated urinary tract infections in adults: results of a prospective, randomized, double-blind multicenter study, Antimicrob Agents Chemother, 46, 2895, 10.1128/AAC.46.9.2895-2900.2002 Wells, 2004, Treatment of complicated urinary tract infection in adults: combined analysis of two randomized, double-blind, multicentre trials comparing ertapenem and ceftriaxone followed by appropriate oral therapy, J Antimicrob Chemother, 53, ii67, 10.1093/jac/dkh208 Bazaz, 2010, Ertapenem administered as outpatient parenteral antibiotic therapy for urinary tract infections caused by extended-spectrum-beta-lactamase-producing Gram-negative organisms, J Antimicrob Chemother, 65, 1510, 10.1093/jac/dkq152 Dalgic, 2011, Ertapenem for the treatment of urinary tract infections caused by extended-spectrum beta-lactamase-producing bacteria in children, Scand J Infect Dis, 43, 339, 10.3109/00365548.2011.553241 Frasca, 2010, Pharmacokinetics of ertapenem following intravenous and subcutaneous infusions in patients, Antimicrob Agents Chemother, 54, 924, 10.1128/AAC.00836-09 Robelet, 2009, Antibiotics given subcutaneously to elderly, Presse Med, 38, 366, 10.1016/j.lpm.2008.07.018 Remington, 2007, Hypodermoclysis to treat dehydration: a review of the evidence, J Am Geriatr Soc, 55, 2051, 10.1111/j.1532-5415.2007.01437.x Hoban, 2011, Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010, Diagn Microbiol Infect Dis, 70, 507, 10.1016/j.diagmicrobio.2011.03.021 Hsueh, 2011, Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region, J Infect, 63, 114, 10.1016/j.jinf.2011.05.015 Zhanel, 2007, Comparative review of the carbapenems, Drugs, 67, 1027, 10.2165/00003495-200767070-00006 Nicolau, 2012, Carbapenem stewardship: does ertapenem affect pseudomonas susceptibility to other carbapenems? A review of the evidence, Int J Antimicrob Agents, 39, 11, 10.1016/j.ijantimicag.2011.08.018